Health News
Duke researchers develop potential HIV vaccine targeting key immune functions
Researchers at the Duke Human Vaccine Institute have developed a promising HIV vaccine candidate that initiates crucial immune responses necessary for fighting the virus.
Duke Health partners with Abridge for AI-driven clinical documentation
Duke Health and Abridge have announced a strategic partnership to explore innovations in healthcare AI.